Related Experiment Video
Updated: Feb 19, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives
Yazhou Liu1,2, Bin Xia3,4, Junjie Lan5,6
1State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. liuyazi19@gmail.com.
Abstract:
Twenty fangchinoline derivatives were synthesized from the natural product fangchinoline, and their anticancer activities on human breast cancer MDA-MB-231 cell line, human prostate cancer PC3 cell line, human melanoma WM9 cell line and human leukaemia HEL and K562 cell lines were evaluated. The biological result showed that those derivatives exhibited potent activities on inhibiting cancer cell growth, and the structure-activity relationships were investigated. Among them, compound 4g, which was protected by benzoyl group in 7-phenolic position and nitrified in 14-position, showed impressive inhibition on all 5 cancer cell lines, especially WM9 cell line, with an IC50 value of 1.07 µM. Further mechanistic studies demonstrated that compound 4g may induce cancer cell death by apoptotic means. These research results suggested that compound 4g could be a lead for the further development toward an anticancer agent against human melanoma WM9 in the future.
Insights
Twenty fangchinoline derivatives were synthesized and tested for anticancer activity. Compound 4g demonstrated potent inhibition against multiple cancer cell lines, particularly melanoma WM9, suggesting its potential as a novel anticancer agent.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Biology
Background:
- Fangchinoline, a natural product, serves as a scaffold for developing new anticancer agents.
- Cancer remains a significant global health challenge, necessitating the discovery of novel therapeutic compounds.
- Existing treatments often face limitations, driving research into alternative therapeutic strategies.
Purpose of the Study:
- To synthesize novel fangchinoline derivatives.
- To evaluate the in vitro anticancer activities of these derivatives against various human cancer cell lines.
- To investigate the structure-activity relationships and identify lead compounds for further development.
Main Methods:
- Synthesis of twenty fangchinoline derivatives from natural fangchinoline.
- Anticancer activity screening using human breast cancer (MDA-MB-231), prostate cancer (PC3), melanoma (WM9), and leukemia (HEL, K562) cell lines.
- Determination of IC50 values and mechanistic studies (apoptosis induction).
Main Results:
- All synthesized derivatives exhibited potent anticancer activities.
- Compound 4g, featuring benzoyl protection and nitration, showed significant inhibition across all tested cancer cell lines.
- Compound 4g displayed remarkable efficacy against WM9 melanoma cells with an IC50 of 1.07 µM.
- Mechanistic studies indicated that compound 4g induces cancer cell death via apoptosis.
Conclusions:
- Compound 4g is a promising lead compound for developing new anticancer therapeutics.
- Fangchinoline derivatives hold potential for treating various cancers, especially melanoma.
- Further research into compound 4g is warranted for its development into a clinical anticancer agent.
More Related Videos
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
